Why Avandia May Increase Your Risk of Heart Attack Death

Avandia, which is a popular diabetes drug, has been associated with a greater risk of heart attack and death. A review published in the New England Journal of Medicine found that there was a 43 percent higher risk of heart attack among people studied.

As of 2007, it was estimated that 6 million people across the world were taking this diabetes medication sold by GlaxoSmithKiline PLC of London. When the report came out that Avandia may lead to heart attack, the company downplayed the heart risks. Glaxo said that the analysis by Dr. Steven Nissen and statistician Kathy Wolski at the Cleveland Clinic was not definitive scientific proof.

Dr. Lawson McCartney, the head of Glaxo’s diabetes drug development, stated that they had not seen anything like the problems reported in the review. “We remain very confident in the safety and of course in the efficacy of Avandia as an important diabetic medicine,” said McCartney.

A press release by Glaxo also commented that the company “continues to support Avandia as safe and effective when used appropriately.”

Avandia is a medication designed to treat Type 2 diabetes, which is the most prevalent form of diabetes. Type 2 diabetes affects approximately 18 million people in the United States and 200 million worldwide. This disease occurs when there is insufficient insulin in the body or when the body cannot effectively use what insulin is produced. Type 2 diabetes has been linked to obesity.

Avandia is supposed to help sensitize the body to insulin and when it was released, it was believed to be a breakthrough medication for blood-sugar control.

If you have suffered serious side effects, including heart attack, while taking Avandia, you may be able to hold the manufacturer accountable for your injuries. You should contact an experienced Tampa injury lawyer who can review your case to determine if you have a claim. Contact the Law Offices of Lilly, O’Toole & Brown, LLP at (863) 683-1111 today for a free consultation.